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Background
Noise-induced hearing loss (NIHL) is a global health
hazard with considerable pathophysiological and social
consequences that has no effective treatment. In the
heart, lung and other organs, cyclic guanosine mono-
phosphate (cGMP) facilitates protective processes in
response to traumatic events.
Results
We therefore analyzed NIHL in mice with a genetic dele-
tion of the gene encoding cGMP-dependent protein kinase
type I (Prkg1) and found a greater vulnerability to and
markedly less recovery from NIHL in these mice as com-
pared to mice without the deletion. Prkg1 was expressed
in the sensory cells and neurons of the inner ear of wild-
type mice, and its expression partly overlapped with the
expression profile of cGMP-hydrolyzing phosphodiester-
ase 5 (Pde5). Treatment of rats and wild-type mice with
the Pde5 inhibitor vardenafil almost completely prevented
NIHL and caused a Prkg1-dependent upregulation of poly
(ADP-ribose) in hair cells and the spiral ganglion, suggest-
ing an endogenous protective cGMP-Prkg1 signaling path-
way that culminates in the activation of poly (ADP-ribose)
polymerase.
Conclusion
These data suggest vardenafil or related drugs as possi-
ble candidates for the treatment of NIHL.
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